SCHEMBL22014850

SCHEMBL22014850

CCc1ccc(S(=N)(N)=O)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 9/20 0.44
CA1 P00915 6/20 0.39
CA12 O43570 5/20 0.39
CA6 P23280 5/20 0.39
CA7 P43166 5/20 0.39
CA13 Q8N1Q1 5/20 0.39
CA9 Q16790 3/20 0.39
CA4 P22748 1/20 0.39
CA5A P35218 1/20 0.39
CA14 Q9ULX7 1/20 0.39
KDM4E B2RXH2 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HTR2A P28223 1/20 0.37
KCNH2 Q12809 1/20 0.37
HRH3 Q9Y5N1 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22792159 0.85 CA2 (0.55) CA2CA1CA12CA6CA7
SCHEMBL20692226 0.81 CA2 (0.41) CA2CA1CA12CA6CA7
SCHEMBL13180189 0.79 KDM4E (0.41) CA2CA1CA12CA6CA7
SCHEMBL27494385 0.75 CA2 (0.41) CA2CA1CA12CA6CA7
SCHEMBL14243210 0.72 HRH3 (0.37) CA2KDM4EL3MBTL1NPC1RAB9A
SCHEMBL12309804 0.72 NPC1 (0.36) CA2KDM4EL3MBTL1NPC1RAB9A
SCHEMBL8038232 0.72 CYP11B1 (0.60) KDM4ENPC1RAB9ASMN1; SMN2HTR2A
SCHEMBL22012201 0.71 CA2 (0.69) CA2CA1CA12CA6CA7
SCHEMBL3129807 0.69 PSIP1 (0.53) CA2CA1CA12CA6CA7
SCHEMBL12409435 0.68 CA2 (0.57) CA2CA1CA12CA6CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102574-A1 THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed